These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 31586724)

  • 1. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
    Wei G; Yang G; Wei B; Wang Y; Zhou S
    Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.
    Wang J; Wu C; Qin X; Huang Y; Zhang J; Chen T; Wang Y; Ding Y; Yao Y
    J Mater Chem B; 2021 Feb; 9(6):1698-1706. PubMed ID: 33495772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
    Du Z; Mao Y; Zhang P; Hu J; Fu J; You Q; Yin J
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35518-35532. PubMed ID: 34286569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
    Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
    Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifunctional nano-delivery system enhances the chemo-
    Zhao R; Ning X; Wang M; Yu A; Wang Y
    J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies.
    Ding Y; Ma Y; Du C; Wang C; Chen T; Wang Y; Wang J; Yao Y; Dong CM
    Acta Biomater; 2021 Mar; 123():335-345. PubMed ID: 33476826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIR-Responsive Polypeptide Nanocomposite Generates NO Gas, Mild Photothermia, and Chemotherapy to Reverse Multidrug-Resistant Cancer.
    Ding Y; Du C; Qian J; Dong CM
    Nano Lett; 2019 Jul; 19(7):4362-4370. PubMed ID: 31199153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
    Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
    Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Assembly Nanoparticles for Overcoming Multidrug Resistance and Imaging-Guided Chemo-Photothermal Synergistic Cancer Therapy.
    Gao H; Bai Y; Chen L; Fakhri GE; Wang M
    Int J Nanomedicine; 2020; 15():809-819. PubMed ID: 32103938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer.
    Shi X; Yang X; Liu M; Wang R; Qiu N; Liu Y; Yang H; Ji J; Zhai G
    Carbohydr Polym; 2021 Feb; 254():117459. PubMed ID: 33357918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
    Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
    Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer.
    You YH; Lin YF; Nirosha B; Chang HT; Huang YF
    Nanotheranostics; 2019; 3(3):266-283. PubMed ID: 31263658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.